Konovo, a technology-first healthcare intelligence company, announced it has acquired Rare Patient Voice (“RPV”), a patient recruitment company with over 200,000 registered patients and family caregivers across rare, chronic, and complex conditions. This strategic acquisition combines RPV's deep patient relationships and proven recruitment expertise with Konovo's intelligent platform, HCP access, and global scale, enabling healthcare researchers to access hard-to-reach patient populations with speed and reliability.
This acquisition expands Konovo's ability to enable patient-centric insights across therapeutic areas, particularly in rare and complex conditions where traditional recruitment methods often fall short. By combining RPV's trusted patient communities with Konovo's platform technology, researchers gain a single solution for engaging and integrating patients and healthcare professionals at scale.
Since launching in 2013, Rare Patient Voice has built a trusted community of patients and family caregivers across nine countries, delivering authentic insights that reflect real-world experiences. Konovo will apply its platform infrastructure and global capabilities to extend RPV's reach while preserving the community-first approach that has made it successful.
"At Konovo, we're focused on solving a core research challenge: accelerating high-quality insights from critical audiences and combining them into a holistic view at scale," said Tal Rosenberg, Chief Executive Officer of Konovo. "Acquiring Rare Patient Voices strengthens our ability to deliver exactly that by bringing together authentic patient perspectives with physician insights to give researchers the complete understanding they need to make confident decisions faster."
“The combination of RPV’s community-centric approach and Konovo’s platform scale creates new opportunities for researchers to engage patient and caregiver audiences more effectively,” said Wes Michael, Founder and President of Rare Patient Voice. “Together we can unlock insights that were previously hard to reach, empowering researchers with the patient perspectives they need to inform decisions and drive innovation.”